NxStage Advances Global Growth Strategy with System One Regulatory Approval and Distribution Agreement in Australia and New Zealand (NXTM)

NxStage Medical, Inc. NXTM, a leading manufacturer of innovative dialysis products, today announced that it has received regulatory approval from Australia's Therapeutic Goods Administration for the NxStage System One™ and signed a five-year agreement, the first year of which is exclusive, with Regional Health Care Group, a leading distributor of medical products in Australia and New Zealand. Under the terms of the agreement with RHCG, the NxStage System One™ and PureFlow™ dialysate preparation system will be available to dialysis centers throughout Australia and New Zealand through RHCG.  RHCG also has the option to make Medisystems bloodlines and ButtonHole needles available to their customers in the region.